Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion

European Journal of Immunology

Volumn 35, Issue 11, 2005, Pages 3240-3247

  Mazzarino, Paola ^a   Pietra, Gabriella ^b   Vacca, Paola ^a   Falco, Michela ^b   Colau, Didier ^c   Coulie, Pierre ^d   Moretta, Lorenzo ^a,b   Mingari, Maria Cristina ^a,e  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^d DE DUVE INSTITUTE   (Belgium)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

Effector memory T cells; HLA E; Human CMV; NK CTL

Indexed keywords

GAMMA INTERFERON; HLA E ANTIGEN; INTERLEUKIN 2; PEPTIDE;

ANTIGEN PRESENTATION; ARTICLE; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMORY CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TARGET CELL;

ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; KILLER CELLS, NATURAL; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 27944510988     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535343     Document Type: Article

References (39)

1. Reddehase, M. J., Antigens and immunoevasins: Opponents in cytomegalovirus immune surveillance. Nat. Rev. Immunol 2002. 2: 831-844.
2. Biron, C. A., Byron, K. S. and Sullivan, J. L., Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 1989. 320: 1731-1735.
3. Arnon, T. I., Achdout, H., Levi, O., Markel, G., Saleh, N., Katz, G., Gazit, R. et al., Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 2005. 6: 515-523.
4. Tomasec, P., Wang, E. C., Davison, A. J., Vojtesek, B., Armstrong, M., Griffin, C., McSharry, B. P. et al., Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol. 2005. 6: 181-188.
5. Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerandolo, V. et al., Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000. 287: 1031-1033.
6. Wang, E. C., McSharry, B., Retiere, C., Tomasec, P., Williams, S., Borysiewicz, L. K., Braud, V. M. et al., UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc. Natl. Acad. Sci. USA 2002. 99: 7570-7575.
7. Mingari, M. C., Vitale, C., Cambiaggi, A., Schiavetti, F., Melioli, G., Ferrini, S. and Poggi, A., Cytolytic T lymphocytes displaying natural killer (NK)-like activity: Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int. Immunol. 1995. 7: 697-703.
8. Pietra, G., Romagnani, C., Falco, M., Vitale, M., Castriconi, R., Pende, D., Millo, E. et al., The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR αβ-mediated recognition. Eur. J. Immunol. 2001. 31: 3687-3693.
9. Romagnani, C., Pietra, G., Falco, M., Millo, E., Mazzarino, P., Biassoni, R., Moretta, A. et al., Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc. Natl. Acad. Sci. USA 2002. 99: 11328-11333.
10. Moretta, L., Romagnani, C., Pietra, G., Moretta, A. and Mingari, M. C., NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol. 2003. 24: 136-143.
11. Rodgers, J. R. and Cook, R. C., MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 2005. 5: 459-471.
12. Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H. and Geraghty, D. E., HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 1998. 160: 4951-4960.
13. Brooks, A. G., Borrego, F., Posch, P. E., Patamawenu, A., Scorzelli, C. J., Ulbrecht, M., Weiss, E. H. et al., Specific recognition of HLA-E, but not classical HLA class I molecules, by soluble CD94/NKG2A and NK cells. J. Immunol. 1999. 162: 305-313.
14. Ulbrecht, M., Modrow, S., Srivastava, R., Peterson, P. A. and Weiss, E. H., Interaction of HLA-E with peptides and the peptide transporter in vitro: Implications for its function in antigen presentation. J. Immunol, 1998. 160: 4375-4385.
15. Ulbrecht, M., Martinozzi, S., Grzeschik, M., Hengel, H., Ellwart, J. W., Pla, M. and Weiss, E. H., The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 2000. 164: 5019-5022.
16. Nattermann, J., Nischalke, H. D., Hofmeister, V., Ahlenstiel, G., Zimmermann, H., Leifeld, L., Weiss, E. H. et al., The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am. J. Pathol. 2005. 66: 443-453.
17. + cytolytic T lymphocytes. Proc. Natl. Acad. Sci. USA 2003. 100: 10896-10901.
18. Chambers, J. A., Angulo, D., Amaratunga, H., Guo, Y., Jiang, J. S., Wan, A., Bittner, K. et al., DNA microarrays of the complex human cytomegalovirus genome: Profiling kinetic class with drug sensitivity of viral gene expression. J. Virol. 1999. 73: 5757.
19. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R. et al., Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol 2001. 19: 197-223.
20. Moretta, L., Bottino, C., Pende, D., Vitale, M., Mingari, M. C. and Moretta, A., Different checkpoints in human NK-cell activation. Trends Immunol. 2004. 25: 670-676.
21. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., Lopez-Botet, M. and Geraghty, D. E., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 1998. 95: 5199-5204.
22. + T cells. J. Exp. Med 1997. 9: 1407-1418.
23. Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
24. - T lymphocytes. Antigenic and functional properties. J. Immunol. 1993. 4: 1147-1159.
25. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA 1996. 93: 12433-12438.
26. Pietra, G., Romagnani, C., Mazzarino, P., Millo, E., Moretta, L. and Mingari, M. C., Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells. Eur. J. Immunol. 2003. 33: 3427-3432.
27. Alcami, A. and Koszinowski, U. H., Viral mechanisms of immune evasion. Immunol. Today 2000. 21: 447-455.
28. Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R. and Spies T., Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2001. 2: 255-260.
29. Cosman, D., Mullberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M. et al., ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001. 14: 123-133.
30. Sutherland, C. L., Chalupny, N. J. and Cosman, D., The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol. Rev. 2001. 181: 185-192.
31. Sutherland, C. L., Chalupny, N. J., Schooley, K., VandenBos, T., Kubin, M. and Cosman, D., UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J Immunol. 2002. 168: 671-679.
32. Braud, V. M., Allan, D. S., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S. et al., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998. 391: 795-799.
33. + T cells contain greatly expanded functional virus-specific memory CTL clones. J. Immunol 1999. 162: 7569-7577.
34. Wills, M. R., Okecha, G., Weekes, M. P., Gandhi, M. K., Sissons, P. J. and Carmichael, A. J., Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response. J. Immunol 2002. 168: 5455-5464.
35. + T cells. J. Immunol 2002. 169: 5838-5843.
36. Sallusto, F., Geginat, J. and Lanzavecchia, A., Central memory and effector memory T cell subset: Function, generation and maintenance. Annu. Rev. Immunol. 2004. 22: 745-763.
37. + cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation. Int. Immunol. 1996. 8: 203-209.
38. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. et al., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 94-96.
39. Moretta, A., Pantaleo, G., Moretta, L., Mingari, M. C. and Cerottini, J. C., Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations. J. Exp. Med. 1983. 158: 571-585.